Follow The Filings

BWAY Brainsway

Brainsway earnings company data as of 4:46 AM ET 10/25

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 10 Nov EPS 0.12 — —
Rev — — —

Insider trades

Open-market buys and sales by BWAY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BWAY insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Gilad Moiseyev Chief Technology Officer
    Sale
    — 5,000 shares 8.6% of stake
    Traded Jun 15 Filed Jun 22
    ↗
  2. Yiftach Roth Chief Scientist
    Sale
    — 7,000 shares 0.6% of stake
    Traded Jun 1–2 Filed Jun 3
    ↗
  3. Rayten Michal Ety Mitrany Director
    Sale
    — 17,980 shares 59% of stake
    Traded May 25–26 Filed May 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 3 share withholdings for taxes and 3 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K FORM 6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
20-F FORM 20-F Filing Doc
6-K FORM 6-K Filing Doc
SCHEDULE 13G — Filing Doc
6-K FORM 6-K Filing Doc
6-K FORM 6-K Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.